Work

Clinical effectiveness, safety and viral mutagenicity of oral favipiravir for COVID-19: Results from a phase II/III trial.

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa3684

Authors: Matthew Tate, Lucy Paterson, Elaine Mccartney, Helene Thygesen, Caroline Kelly, Rory Gunson, Janet T. Scott, Laura Divers, Laura Cunningham, Jon Perkins, Vanessa Silva, Poppy Holland, Christopher R.J. Illingworth, Sreenu Vattipally, Ana Da Silva Felipe, Emma C. Thomson, Michael E. Murphy, Gordon Macgregor, Kevin G. Blyth

Institutions: Queen Elizabeth University Hospital, Glasgow Royal Infirmary, MRC University of Glasgow Centre for Virus Research, University of Glasgow

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104591

Cites:

Cited by:

Related to: 10